Table 1.

Country-specific CA-MRSA carriage prevalence

Community settings					Hospital settings
Studies	Study numbera	Study start year	Prevalence (%)	Binomial 95% CIb	Studies	Study numbera	Study start year	Prevalence (%)	Binomial 95% CIb
Australia
Munckhof et al 200950	95	2005	0.3	0.0, 1.0	Brennan et al 201366	6	2009	0.9	0.1, 3.2
					Brennan et al 201366	7	2010	10.4	6.6, 15.5
					Verwer et al 201258	132	2007	2.8	2.0, 3.7
China
Chen et al 201551	21	2013	0.3	0.0, 1.9
India
Goud et al 201152	32	2003	16.5	13.9, 19.4	George et al 201659	30	2012	2.3	1.3, 3.8
Jain et al 201453	56	2006	23.5	17.8, 30.0
Taiwan
Lu et al 200554	88	2001	3.5	2.7, 4.4	Chang et al 201560	10	2014	3.6	1.0, 9.0
Wang et al 200955	136	2007	3.8	3.2, 4.6	Chen et al 201061	17	2008	3.4	1.3, 7.2
					Wang et al 201062	141	2008	1.8	1.2, 2.6
South Korea
Ro et al 201256	114	2007	1.1	1.0, 1.1	Park et al 201663	107	2007	2.6	2.4, 2.8
Vietnam
Van Nguyen et al 201457	131	2012	7.9	6.3, 9.7
Nepal
					Joshi et al 201764	62	2014	0.7	0.2, 1.9
New Zealand
Williamson et al 201365	144	2005	0.0c	0.0, 0.0
Range (%)			0.0–23.5					0.7–10.4

Notes:

^aRefer to Appendix VIII for study details;

^bClopper–Pearson exact transformation;

^cThe precise value is 0.009%.

Abbreviation: CA-MRSA, community associated methicillin-resistant Staphylococcus aureus.